Status:
UNKNOWN
An Observational, Qualitative Study Assessing Eye Drop Administration
Lead Sponsor:
Ocular Therapeutix, Inc.
Conditions:
Ocular Injury
Eligibility:
All Genders
Brief Summary
This is a prospective, observational, consecutive, qualitative, multicenter study. Based on the available published evidence that supports patient challenges with eyedrop administration, the purpose o...
Detailed Description
Introduction: This is a prospective, observational, consecutive, qualitative, multicenter study. A robust body of evidence suggests patients demonstrate challenges with eyedrop adherence and improper ...
Eligibility Criteria
Inclusion
- Patients or parents of minor patients who consent to participating in the study
Exclusion
- Any patient who does not consent to study participation
Key Trial Info
Start Date :
April 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05307081
Start Date
April 21 2022
End Date
December 1 2023
Last Update
September 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vance Thompson Vision
Sioux Falls, South Dakota, United States, 57108